Dynamics of spontaneous ventricular fibrillation in acutely ischemic pigsDesaive, Thomas ; Janssen, Nathalie ; et alin Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology (2006), 8 (supplement 1) Detailed reference viewed: 63 (40 ULg) First and second generations of COX-2 selective inhibitors; ; et al in Mini Reviews in Medicinal Chemistry (2004), 4 Detailed reference viewed: 19 (3 ULg) Progress in the field of GPIIb/IIIa antagonistsHanson, Julien ; ; David, Jean-Louis et alin Current Medicinal Chemistry - Cardiovascular and Hematological Agents (2004), 2 Detailed reference viewed: 13 (0 ULg) Design, synthesis and pharmacological evaluation of pyridinic analogues of nimesulide as cyclooxygenase-2 selective inhibitors; ; et al in Journal of Medicinal Chemistry (2004), 47 Detailed reference viewed: 9 (2 ULg) Identification of COX-2 selective inhibitor; ; et al in Fundamental & Clinical Pharmacology (2004) Detailed reference viewed: 5 (1 ULg) New developments on thromboxane modulators; Hanson, Julien ; et alin Mini Reviews in Medicinal Chemistry (2004), 4 Detailed reference viewed: 3 (1 ULg) Recent development in the field of dual COX / 5-LOX inhibitors; ; Pirotte, Bernard et alin Mini Reviews in Medicinal Chemistry (2004), 4 Detailed reference viewed: 4 (1 ULg) Recent developments in 5-lipoxygenase inhibitors; ; et al in Expert Opinion on Therapeutic Patents (2003), 13 Detailed reference viewed: 1 (0 ULg) Pharmacological evaluation of the novel thromboxane modulator BM-567 (II/II). Effects of BM-567 on osteogenic sarcoma-cell-induced platelet aggregation; ; et al in Prostaglandins, Leukotrienes, and Essential Fatty Acids (2003) Detailed reference viewed: 6 (1 ULg) Spectral and crystallographic study of pyridinic analogues of nimesulide : determination of the active form of methanesulfonamides as COX-2 selective inhibitors; ; et al in Journal of Medicinal Chemistry (2002), 45 Detailed reference viewed: 9 (4 ULg) Advances in the field of COX-2 inhibition; ; et al in Expert Opinion on Therapeutic Patents (2002), 12 Detailed reference viewed: 4 (1 ULg) New trends in dual 5-LOX/COX inhibition; ; et al in Current Medicinal Chemistry (2002), 9 Detailed reference viewed: 5 (0 ULg) N-(3-Phenoxy-4-pyridinio)methanesulfonamidate; ; et al in Acta Crystallographica (2002) Detailed reference viewed: 9 (4 ULg) Evaluation of classical NSAIDs and COX-2 selective inhibitors on purified ovine enzymes and human whole blood; ; et al in Prostaglandins, Leukotrienes, and Essential Fatty Acids (2001), 64 Detailed reference viewed: 8 (0 ULg) Synthesis and evaluation of non-carboxylic pyridinic derivatives as cyclooxygenase inhibitors; ; et al in Mediators of Inflammation (2000), 9 Detailed reference viewed: 8 (1 ULg) Profile of nimesulide and nimesulide-L-lysine-β-cyclodextrin on chondrocyte metabolism; ; et al in Fundamental & Clinical Pharmacology (2000), 14 Detailed reference viewed: 5 (0 ULg) Comparison of the effects of nimesulide and nimesulide-L-lysine on PGE2 production by COX-1 and COX-2 and on chondrocyte metabolism in vitro; ; et al in Pharmacy and Pharmacology Communications (2000), 6 Detailed reference viewed: 2 (2 ULg) 7-Substituted alkylamino-4H-1,2,4-benzothiadiazine 1,1-dioxides as new analogues of diazoxide: effects on the insulin releasing process in vitro; ; et al in Fundamental & Clinical Pharmacology (2000), 14 Detailed reference viewed: 4 (2 ULg) Evaluation of classical NSAIDs on COX-1 and COX-2 purified enzymes and prognosis of their effects on physiological responses; ; et al in Fundamental & Clinical Pharmacology (2000), 14 Detailed reference viewed: 2 (0 ULg) Recent advances in inducible cyclooxygenase (COX-2) inhibition; ; et al in Current Medicinal Chemistry (2000), 7 Detailed reference viewed: 4 (3 ULg) |
||